These melanoma cells express high levels of the neurotrophic factor brain-derived neurotrophic factor (BDNF), and inhibition of either BDNF or NGFR enhances sensitivity to T cell-mediated tumor killing. The gene discussed is NGFR; the disease is neoplasm.